Treatment News : Discovery About HIV Could Lead to New Prevention and Treatment Approaches

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Treatment News » January 2011

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

January 25, 2011

Discovery About HIV Could Lead to New Prevention and Treatment Approaches

Researchers have discovered how HIV is able to reproduce within a type of immune cell called a macrophage and how it evades many of the most common antiretroviral (ARV) therapies. This new finding was published December 10 in The Journal of Biological Chemistry and detailed in a release from the University of Rochester in New York.

Macrophages serve as one of the first lines of defense against viruses, bacteria and other microbes. The Greek term macrophage translates into English as “big eater,” which describes their function—to engulf an infectious organism and then present small bits of it to other immune cells. This helps provoke a strong response against the invaders. HIV, however, is able to hijack macrophages and use them to infect other cells.

Baek Kim, PhD, from the University of Rochester, has been studying macrophages for more than 15 years in hopes of understanding fully how HIV is able to hijack the molecular machinery of macrophages and turn it to the advantage of the virus. Now, he and other researchers at the University of Rochester and Emory University in Atlanta, report that they’ve figured it out.

It turns out that HIV is able to utilize more than one type of molecular “tool” in order to reproduce inside cells. It is widely known that HIV commonly uses a molecule called deoxynucleoside triphosphate (dNTP) to build strings of HIV DNA that turn most other immune cells into virus factories. This molecule, however, is in short supply inside macrophages. For this reason, HIV’s ability to replicate inside macrophages has remained somewhat of a mystery. What Baek and his team discovered, however is that HIV can turn to another type of molecule, called ribonucleoside triphosphate (rNTP), when dNTP has been knocked out.

“The virus would normally just use dNTP, but it’s simply not available in great quantities in the macrophage. So HIV begins to use rNTP, which is quite similar from a chemical perspective. This is a surprise,” Kim said. “The virus just wants to finish replicating, and it will utilize any resource it can to do so.”

The findings will need to be confirmed by further research, and it will take some time to determine whether they can be applied to treat or prevent new infections. However, one of Kim’s partners in this research, Raymond Schinazi, PhD, from Emory says this finding could have significant implications for both HIV treatment and prevention.

Many ARVs target the molecule dNTP. Kim’s finding that the virus can also use rNTP means that such drugs may not effectively target macrophages and shut down viral reproduction there. Since macrophages are the first cells that HIV encounters, current ARVs might not be able to effectively block infection. Likewise, once a person is infected, the macrophages that line the gut and inhabit lymph nodes might also be resistant to the effects of typical ARVs.

“This significant breakthrough was unappreciated prior to our paper. We are now exploiting new [ARV] drugs jointly based on this novel approach that are essentially not toxic and that can be used to treat and prevent HIV infections,” Schinazi said.

Search: Macrophage, deoxynucleoside triphosphate, dNTP, ribonucleoside triphosphate, rNTP, Baek Kim, Raymond Schinazi, prevention, treatment


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Hide comments

Previous Comments:


  comments 1 - 2 (of 2 total)    

Andy, , 2011-02-15 18:38:53
This is great news unfortunately it will probably be taken by those who make big money from HIV and swept under the rug unless they can figure out a way to make money from it without curing HIV

pos83diag92alive11, Boston, 2011-01-26 21:36:52
This research is IMHO the type that can be a game changer. Medications that can keep macrophages from becoming infected would be the ultimate post-exposure prophylaxis to prevent the virus from taking hold. It is clear that the gut and the bone marrow remain the two reservioirs that must be drained for any hope of an HIV "cure'...this is solid research and possibly IMHO Nobel quality research-scientists have not understood macrophage inability to fight off HIV and this could turn page.

comments 1 - 2 (of 2 total)    


[Go to top]


Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV 101
HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
Disclosing Your Status
Starting Treatment
Search for the Cure
POZ Stories
POZ TV
Read the Blogs
Visit the Forums
Women
African American
Latino
Providers
Job Listings
Events Calendar


    guycmh328
    Columbus
    Ohio


    newlife202
    JOLIET
    Illinois


    youngbloodlatino
    Columbia
    Maryland

This could be you!
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Do you enjoy books with HIV-positive characters?
Yes
No

Survey
Mind Matters

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.